After an uproar from players and fans alike this spring, Nike Inc. will reportedly fix a…
Author: Arthur Bleemer
Stocks risk a wild week with Big Tech earnings, Fed’s faceoff with inflation
“Magnificent Seven” stocks are driving market volatility. It isn’t the only worry.
Nvidia’s Jensen Huang says human jobs won’t just go away because of AI
Nvidia Inc. chips are powering the artificial-intelligence revolution. But while Chief Executive Jensen Huang thinks AI…
Why the Fed looks likely to scramble back to a hawkish stance
Here are some of the biggest questions facing Fed officials going into this week’s meeting.
Fulton Financial acquires Republic First Bank after first U.S. bank failure of 2024
After struggling under the weight of higher interest rates, Republic First Bancorp on Friday found another…
AMC takes a hit from Hollywood strikes, but narrows quarterly loss
AMC reported preliminary first-quarter earnings late Friday, ahead of expectations that it would report the results…
Microsoft earnings were solid — and here’s why they’re primed to get even better
Azure hasn’t had quite enough capacity to meet booming AI demand, and Copilot software tools should…
Big Tech drives S&P 500 to best week since November as investors shrug off inflation worries
U.S. stocks pared their April losses on Friday, with the S&P 500 booking its biggest weekly…
‘I racked up $45,000 in credit-card debt doing home repairs’: Should I refinance my $1.5 million house — or take out a personal loan to pay it off?
“We live in a very strong housing market in Los Angeles so we’re not worried about…
This man claims Tom Brady’s sloppy signature turned $500,000 worth of collectibles into defaced keepsakes
Fans attending a Miami event featuring the gridiron great say he “scribbled” on valuable pieces of…
Here’s how much money the top 2024 NFL draft picks will earn on their rookie contracts
Dropping a few spots can cost players millions. In 2023, Kentucky quarterback prospect Will Levis was…
Gilead’s quarterly loss is narrower than expected
Gilead Sciences Inc.’s stock dipped 0.2% in after-hours trading Thursday, after the drug company’s adjusted first-quarter…